Arog’s Phase III trial of crenolanib met its primary endpoint and improved OS and EFS in patients with NPM1/FLT3 co‑mutated ...
Childhood psychosis risk appears to increase significantly among carriers of this gene variant. In A Nutshell First ...
YouTube creators report sudden channel bans for spam policies, with some restored after public outcry. YouTube claims the ...
The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...
First data reported from non-MTS and bilateral MTLE subjects demonstrate robust seizure reduction - LOW DOSE COHORT: 89% median reduction in disabling seizures for unilateral subjects with MTS at the ...
In a study published in the New England Journal of Medicine, Delp, a professor of bioengineering, and his collaborators ...
Objectives Bedaquiline (BDQ), delamanid (DLM) and pretomanid (Pa) were widely used in recent years. This study aimed to analyse adverse drug event (ADE) reports associated with them based on the Food ...
Explore the significance of exercise, particularly strength training, to healthy aging, and mitigating the risk of chronic ...
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with ...
Final Decision from European Commission Expected in Q1 2026SOUTH SAN FRANCISCO, Calif., (GLOBE NEWSWIRE) -- Cytokinetics, ...
Barclays 23rd Annual Global Technology Conference December 11, 2025 4:20 PM ESTCompany ParticipantsJeffrey Stibel - CEO ...
Institute of Neuroscience, Howard Hughes Medical Institute, University of Oregon, Eugene, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback